This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Mary Lou Szekeres
Director, Channel Marketing at Geron Corporation
Speaker

Profile

Mary Lou Szekeres joined Geron from Daiichi Sankyo where she led the market access launches for ENHERTU for the gastric and NSCLC indications. Mary Lou has over 30 years working in healthcare marketing with the majority of that concentrated on market access. Mary Lou is currently at Geron leading the U.S. market access and strategy. She led the launch of RYTELO and was instrumental in developing affordability solutions to support seamless patient access. Previous company experience includes a variety of agency positions including McCann Health Market Access and Eversana to name a few. Mary Lou earned a B.A in English from Fairfield University and a M.B.A, in Marketing from CUNY, Baruch. Additionally, Mary Lou is a Prior Authorization Certified Specialist (PACS).

Agenda Sessions

  • Section 2: Bridging Two Worlds – Tailoring Launch Strategies for Rare Disease vs. Non-Specialty Markets

    1:45pm